We recently established that neprilysin (NEP), one of the putative amyloid b-peptide (Ab)-degrading enzymes, is transcriptionally upregulated by AICDs, the C-terminal fragments of the b-amyloid precursor protein (bAPP/APLP) that are generated by presenilin (PS)-dependent g-and 3-secretase activities (Pardossi-Piquard et al., 2005) . Chen and Selkoe now report lack of evidence of NEP upregulation by PS-dependent g-secretase. To explore the reasons for this difference, we have repeated several experiments, conducted new experiments, and carefully examined the data presented by Chen and Selkoe. These analyses reveal that (1) there is significant consensus in key experimental data; (2) several of Chen and Selkoe's negative conclusions are overreaching, arising from a crucial conceptual error on their part; and (3) there is compelling, independent data from experiments in nicastrin null cells and in brain from transgenic mice overexpressing AICD that support the notion that presenilin complexes and AICD modulate inducible NEP expression.
Results and Discussion
There is consensus on several important points. Both groups find that NEP expression is dramatically reduced in PS1 À/À :PS2 À/À double-knockout mouse embryonic fibroblasts (MEFs) (Figures 1D and 1E in Pardossi-Piquard et al., 2005; Figures 1A and 1B in this paper; Figure 1C in Chen and Selkoe, 2007) . Both groups find modest reductions (%25%) in NEP expression in PS1 À/À :PS2 À/À double-knockout BD8 blastocyst cells (Figures 1F and 1G in Pardossi-Piquard et al., 2005; Figure 1A in Chen and Selkoe, 2007) . Both groups observe either modest or no consistent change in NEP expression in single-knockout -Piquard et al., 2005; Figures 1A and 1B in this paper; Figures 1C and 4C in Chen and Selkoe, 2007) . Repetition of several of our experiments using different MEF cell lines and different anti-NEP antibodies reveals that the results are unchanged ( Figures 1A and 1B) . This argues against an artifact arising from laboratory error or from differences in clones. We have also pursued additional experiments, both of which strongly support the validity of our initial report.
First, we investigated NEP activity, protein, and mRNA levels in nicastrin knockout MEFs (NCT À/À ), which do not form functional presenilin complexes and which have no g-secretase activity (Yu et al., 2000) . NEP expression, NEP activity, and NEP mRNA levels were all dramatically reduced in nicastrin knockout MEFs (NCT transfection with NCTcDNA ( Figure 1C ). This effect was specific because NCT cDNAs do not restore NEP expression in PS À/À fibroblasts ( Figure 1C ). These data are fully consistent with the in vitro data from both our group and from Chen and Selkoe, which show downregulation of
Second, we examined NEP expression in the brain of transgenic mice overexpressing Fe65 and AICD (Ryan and Pimplikar, 2005) . AICD:Fe65 double-transgenic mice displayed enhanced cerebral expression of NEP compared to Fe65 single-transgenic mice (Figure 2) . These data therefore reinforce our conclusion that NEP can be transcriptionally controlled by AICDs generated by g-secretase-cleavage of bAPP and its family members (i.e., APLPs).
Taken together, the experimental data described above and our prior observations (several components of which are congruent with those of Chen and Selkoe) support the conclusion that functional presenilin/g-secretase complexes mediate inducible NEP expression via AICDs. However, inspection of the experimental assumptions and the experimental design used by Chen and Selkoe reveals several explanations for their different interpretation of similar experimental data.
First, Chen and Selkoe have made a fundamental and critic conceptual error. They failed to take into account the fact that inducible NEP expression is modulated by AICD products that are derived by a highly redundant system (Pardossi-Piquard et al., 2005) . Thus, AICDs can be generated from either APP or the APLP homologs. g-secretase activity is mediated by either PS1 or PS2. Recognition of the simultaneous redundancy in the presenilins and in AICD signaling is critical to the correct interpretation of experiments
). Thus, Chen and Selkoe point out that PS1 Figure 1C , lanes 4-6 versus 10-12 of Chen and Selkoe, 2007) and that this constitutes evidence that NEP expression is not modulated by PS1. The observation itself is not in doubt. Our data also show that NEP expression is not altered in PS1
-only MEFs ( Figure 3C in Pardossi-Piquard et al., 2005) . However, the conclusion that NEP expression is not modulated by PS1 is overreaching and incorrect because it makes the assumption that the residual PS2 has no activity. While PS1 may be ''dominant'' over PS2 for the g-secretase cleavage of APP, it overlooks the fact that inducible NEP expression is also regulated by g-and 3-cleavage of APLPs. There are no data to show that PS1 and PS2 differ in terms of g-and 3-cleavage of APLPs.
The Figure 1A of Chen and Selkoe, 2007) . The small proportion of NEP that is PS inducible and the high level of constitutive NEP expression clearly make it difficult to reliably detect small (<25%) changes in inducible NEP expression. The second reason that we chose not to use PBD8 and BD8 is that they have poor and variable transfection efficiencies. Inspection of Figure 1B from Chen and Selkoe reveals clear evidence of such variability in BD8 cells. This transfection variability has significant effects on PS1 expression and g-secretase complex formation. For instance, in lanes 8-9 in Figure 1B , which are labeled as BD8 cells transfected with both PS1 and PS2 cDNA, there is in fact (1) essentially no PS1 expression, (2) only a very small percentage of nicastrin in maturely glycosylated forms (a marker of incorporation into mature functional PS complexes), and (3) only minimal decrease in APP-CTFs, which represents at best a 30% reduction from baseline and is not better than PS2 complementation alone (N.B. PS2 does not normally fully complements APP processing in PS1 deficiency). The important issue here, however, is not the PS1 and PS2 levels but whether biologically effective g-secretase activity has been restored in relevant subcellular compartments by their transfection. It is apparent from both the minimal levels of maturely glycosylated NCT and the small reduction in APP-CTF levels in lanes 4-9 of Figure 1B of Chen and Selkoe that g-secretase activity has been only poorly restored in these transfected BD8 cells. This failure to robustly restore g-secretase activity severely limits the negative conclusions that can be safely drawn from BD8 cells. Despite these two confounders, Chen and Selkoe derive much of their data and conclusions from BD8 blastocyst-derived cells.
A third source of concern relates to the magnitude of the change in PSdependent signaling that is necessary to produce a discernable change in inducible NEP expression. Because the threshold for induction of NEP is unknown (and is likely cell-type specific), reasonable grounds for rejection of the hypothesis that PS-dependent signaling modulates inducible NEP expression would be the demonstration of no change in NEP expression following unambiguous changes in PS-dependent signaling. Many of the PS-complementation and g-secretase inhibitor studies in Chen and Selkoe do not achieve robust changes in PSdependent signaling. MEFs in their Figure 1D caused (1) only minimal induction of maturely glycosylated nicastrin and (2) only minimal reduction in APP-CTFs (<30% reduction) compared to untransfected PS1 À/À :PS2 À/À cells. It is unclear that significant amounts of g/3-secretase activity were restored to biologically relevant compartments in these knockout cells. Similar concerns arise about many of their g-secretase inhibitor studies (Figure 2A and Figure S2 of Chen and Selkoe, 2007) . In many of these studies, the post-dose accumulation of APP-CTF (a marker of the efficiency of g-secretase activity) is at best minimal. The same argument also pertains to the AICD transfection studies ( Figures 3A and 3B of Chen and Selkoe), where AICD is at trace levels in most cells, even when triple transfected with Fe65+Tip60+AICD. There are, however, two figures from Chen and Selkoe that might, at first pass, be taken to support their interpretation. Figure 2C of Chen and Selkoe appears to show no decrease in NEP levels in MEF cells treated with the g-secretase inhibitor DAPT, despite a robust increase in APPCTFs. However, closer inspection reveals that this experiment is seriously flawed and is uninterpretable without additional controls. Specifically, the untreated neprilysin knockout MEFs show APP-CTFs levels that are identical to those in MEFs treated with g-secretase inhibitors (compare Chen and Selkoe, 2007: Figure 2C , lane 13 versus lanes 7-12). This makes little sense and throws into question the design of this experiment, raising the possibility that DMSO treatment of the ''control'' MEFs (Chen and Selkoe, 2007: Figure 2C , lanes 1-6) has had some complex toxic effect. Even if one disregards this, since the amount of DAPT used by Chen and Selkoe is low (500 nM versus 2 mM in our study), it is far from clear that this experiment will have significantly affected 3-cleavage-dependent production of AICDs. Data on AICD levels were not shown.
Similar technical concerns pertain to Figure 3C of Chen and Selkoe, which appears to show robust expression of AICD (C60) in HEK293T cells triple transfected with AICD/C60, Fe65, and Tip60 (Chen and Selkoe, 2007) : Figure 3C , lanes 11 and 12). However, the identity of this band is unclear. Close inspection of the AICD Western blot in Figure 3C reveals an AICD/C60 immunoreactive band pattern that is very different from the AICD/C60 pattern observed with the same antibody in their other figures (Figures 2A, 3A , and 3B of Chen and Selkoe). The latter figures all show a dark invariant band and a light AICD band beneath it. Even if this concern is dismissed, Chen and Selkoe have not proven that the highly labile AICD transfected into these cells was delivered to the nucleus. Without this positive control, it is premature to conclude that transfection of cells with AICD had no effect on NEP transcription. By contrast, we clearly showed that transcriptional upregulation of NEP was accompanied by nuclear AICD immunoreactivity in AICD-transfected cells ( Figure 5D in Pardossi-Piquard et al., 2005) .
In their final paragraph, Chen and Selkoe argue on theoretical grounds that PS-dependent induction of NEP via AICD is improbable because neprilysin degrades other biologically active peptides, because AICD is also a product of non-Ab-generating proteolysis of APP, and because there is unlikely to have been evolutionary pressure for the development of a specific mechanism just to upregulate Ab degradation by NEP. None of these theological arguments compellingly dismiss the biological evidence that AICDs, generated by PS-dependent g-secretase activity, do in fact modulate NEP transcription in some cells. Without knowing the functions of APP/APLP and of their ligands, and without knowing the identity of the downstream targets of AICD and Ab, it is difficult to know what underlying biological purpose was originally intended in evolution for this pathway. However, the rather narrow Ab/APPcentered interpretation proposed by Chen and Selkoe seems unnecessary. It is more probable that AICD-mediated upregulation of NEP is designed to allow proteolytic regulation of a variety of biologically active peptides, including Ab.
On balance, therefore, given the persistence of experimental support both in vitro (recovery of reduced NEP expression in NCT À/À cells by transfection with NCT) and in vivo (higher NEP levels in brain tissue from mice overexpressing AICD), our interpretation remains that many, but perhaps not all, cells show PS-dependent inducible NEP expression.
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